Covestor’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45K Buy
86
+4
+5% +$2.19K 0.03% 788
2026
Q2
$43K Buy
82
+4
+5% +$2.24K 0.02% 874
2026
Q1
$44K Sell
78
-20
-20% -$12.8K 0.03% 779
2025
Q4
$67K Sell
98
-65
-40% -$44.3K 0.04% 784
2025
Q3
$104K Sell
163
-49
-23% -$29.7K 0.06% 562
2025
Q2
$114K Sell
212
-6
-3% -$2.87K 0.07% 471
2025
Q1
$92K Buy
218
+19
+10% +$8.25K 0.06% 544
2024
Q4
$83K Sell
199
-4
-2% -$1.76K 0.05% 629
2024
Q3
$103K Buy
203
+21
+12% +$10.2K 0.06% 495
2024
Q2
$88K Buy
182
+111
+156% +$55.7K 0.06% 576
2024
Q1
$39K Buy
71
+8
+13% +$4.37K 0.02% 971
2023
Q4
$36K Sell
63
-4
-6% -$1.88K 0.02% 982
2023
Q3
$29K Buy
67
+28
+72% +$14K 0.02% 991
2023
Q2
$20K Hold
39
– – 0.02% 1135
2023
Q1
$20K Sell
39
-14
-26% -$6.7K 0.02% 1002
2022
Q4
$21K Buy
53
+9
+20% +$3.49K 0.02% 1018
2022
Q3
$15K Buy
44
+1
+2% +$367 0.01% 1095
2022
Q2
$15K Sell
43
-74
-63% -$30.2K 0.01% 1059
2022
Q1
$64K Hold
117
– – 0.04% 718
2021
Q4
$77K Buy
+117
New +$73.4K 0.11% 290

Other funds holding IDXX

Covestor's IDXX Position: Q3 2026 in Review

Covestor increased its Idexx Laboratories (IDXX) stake by 4.9% in Q3 2026, buying an estimated $2.19K and bringing the position to 86 shares worth $45K. The position accounts for 0.03% of the portfolio, ranked #788.

Covestor first reported a position in IDXX in Q4 2021 and has held it in 20 quarters since. The position peaked at $114K in Q2 2025. 1,276 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Covestor held 86 shares of Idexx Laboratories worth $45K as of Q3 2026.
  • Covestor bought 4 Idexx Laboratories shares in Q3 2026, an estimated $2.19K.
  • Idexx Laboratories made up 0.03% of Covestor's portfolio in Q3 2026, its #788 holding.
  • Covestor first reported a position in Idexx Laboratories in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Idexx Laboratories position peaked at $114K in Q2 2025.
  • 1,276 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.